In a report released today, Sean Wieland from Piper Jaffray reiterated a Buy rating on Tivity Health Inc (NASDAQ: TVTY), with a price target of $43. The company’s shares closed yesterday at $33.90.
According to TipRanks.com, Wieland is a top 100 analyst with an average return of 26.8% and a 70.8% success rate. Wieland covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, Medidata Solutions, and Quality Systems.
Currently, the analyst consensus on Tivity Health Inc is a Strong Buy with an average price target of $45, implying a 32.7% upside from current levels. In a report released yesterday, Cantor Fitzgerald also maintained a Buy rating on the stock with a $49 price target.
.
See today’s analyst top recommended stocks >>
Tivity Health Inc’s market cap is currently $1.35B and has a P/E ratio of 22.65. The company has a Price to Book ratio of 4.59.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tivity Health, Inc. engages in the development and provision of network solutions and health management services. It offers rehabilitative therapy, chiropractic procedure, alternative medicines, and health and fitness programs under the SilverSneakers, Prime Fitness, and WholeHealth Living trademarks.
